The status and challenges of HPV vaccine programme in China: an exploration of the related policy obstacles

⇒ China has a high burden of human papillomaviruses (HPV)-related cancers, with the second highest incidence and mortality rate of cervical cancer worldwide.⇒ Financial constraints, regional restrictions and gender-specific vaccination policies have led to disparities in HPV vaccination rates across China.⇒ Public perceptions of the HPV vaccine vary widely, with factors such as lack of confidence, accessibility and awareness influencing vaccine uptake.⇒ Recommendations include increasing government funding for the HPV vaccine, expanding vaccine coverage, improving vaccine delivery yield, regulating injection pathways and enhancing scientific education on the HPV vaccine to raise awareness and increase vaccine uptake.